Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 7, 2022
December 9, 2022
eb835388-a1e0-46db-8c55-61853bcee91b
Related Documents
Alternative Procedures for the Manufacture of Cold-Stored Platelets Intended for the Treatment of Active Bleeding when Conventional Platelets Are Not Available or Their Use Is Not Practical: Guidance for Industry
Guidance DocumentJune 23, 2023Center for Biologics Evaluation and Research
Recommendations to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Components: Guidance for Industry
Guidance DocumentMay 23, 2022Center for Biologics Evaluation and Research
Biological Product Deviation Reporting for Blood and Plasma Establishments: Guidance for Industry
Guidance DocumentMarch 12, 2020Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox